Chris L. Pashos

Chris L. Pashos possesses extensive experience in health economics, outcomes research, and strategic leadership within the pharmaceutical industry. Currently serving on the Board of Directors at Genesis Research and as a member of the Board of Advisors at OtisHealth, Chris has held senior roles at AbbVie and Takeda, including Vice President positions focused on global evidence strategy and epidemiology research. Previous leadership at United BioSource Corporation and ISPOR highlights Chris's commitment to advancing health policy and outcomes research. Academic contributions include a faculty position at Harvard Medical School, and educational credentials include a PhD and MPP from Harvard University and a BS from the United States Naval Academy.